Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Lusofarmaco develops new angiotensin antagonists

Jan. 13, 1998

Efficacy established for ET antagonist in pulmonary hypertension

Jan. 13, 1998

Ketoacid ETA antagonists from Warner-Lambert

Jan. 12, 1998

NIH seeks CRADA partners or licensees for 12-LO metabolite

Jan. 9, 1998

NIH announces contemplation of licensing agreement for growth factors

Jan. 9, 1998

Beaufour Ipsen to market Tanabe ACE inhibitor

Jan. 9, 1998

Barr receives additional generic approval

Jan. 9, 1998

Flocor enters phase I for ACS

Jan. 8, 1998

Heparinase III efficacy established in preclinical model

Jan. 8, 1998

PLC Systems submits requested data related to Heart Laser PMA

Jan. 7, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...